Fair Isaac Corporation: Wells Fargo cuts target price to $735 from $800
FICO•Wells Fargo cut its target price for Fair Isaac Corporation to $735 from $800.
Related News
Iovance's lifileucel shows 50% response rate in soft tissue sarcoma pilot trial
IOVA•
Enanta doses first patient in Phase 2b/3 trial of RSV drug zelicapavir
ENTA•
Eledon’s Tegoprubart improves quality of life versus tacrolimus in Phase 2 kidney transplant trial
ELDN•
Lakeland Financial Q3 net income rises on commercial loan growth
LKFN•
InMode publishes shareholder letter from special committee
INMD•